Identification and Management of Diabetic Nephropathy in the Diabetes Clinic
Open Access
- 1 June 2003
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (6) , 1806-1811
Abstract
OBJECTIVE—To examine the prevalence and management of diabetic nephropathy in a diabetes clinic. RESEARCH DESIGN AND METHODS—Characteristics of nephropaths identified by existing screening practice (phase I, albuminuria >20 mg/l in three separate urine samples), were compared with those identified by a nurse-led management program (phase II, in which screening for nephropathy was based on albumin-to-creatinine ratio in a single random urine specimen). RESULTS—In phase I, 644 patients attended a diabetes clinic over a 6-month period. Microalbuminuria results were available for 485 patients (75%). A total of 115 patients were identified as nephropaths (prevalence 17.8%). Of these patients, 91% had type 2 diabetes. During phase II, prospective analysis of urinary albumin-to-creatinine ratio was carried out in 880 patients over 8 months. A total of 174 patients were identified as nephropaths (prevalence 20%). Of these, 134 patients had been identified by existing screening protocols. Forty had no previous record of microalbuminuria and were therefore newly identified by prospective screening. Systolic blood pressure guidelines were met in only 31% of all known nephropaths and 26.5% of newly diagnosed nephropaths. Diastolic blood pressure guidelines were met in 36% of all known and 38% of newly diagnosed nephropaths. In the patient group of known nephropaths from phases I and II, 62% were prescribed ACE inhibitors (ACEIs) or angiotensin II receptor (AIIR) antagonists. In the newly identified nephropathy patient cohort from phase II, 48% used ACEIs or AIIR antagonists. CONCLUSIONS—Introduction of a nurse-led management program significantly improved detection of nephropathy. We are currently evaluating its impact on clinical management.Keywords
This publication has 33 references indexed in Scilit:
- Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokesKidney International, 2002
- Diabetic nephropathy: how effective is treatment in clinical practice?QJM: An International Journal of Medicine, 2002
- Can intensive treatment alter the progress of established diabetic nephropathy to end-stage renal failure?QJM: An International Journal of Medicine, 1999
- Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyThe Lancet, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Quality of Outpatient Care Provided to Diabetic Patients: A health maintenance organization experienceDiabetes Care, 1996
- Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications TrialKidney International, 1995
- Use of Single Voided Urine Samples to Estimate Quantitative ProteinuriaNew England Journal of Medicine, 1983
- Long-term antihypertensive treatment inhibiting progression of diabetic nephropathyBMJ, 1982
- The sad truth about hemodialysis in diabetic nephropathy1972